On October 28, 2024, the Breakthrough T1D Centre of Excellence at the University of British Columbia (UBC) held its third annual meeting on UBC campus in Vancouver to discuss progress […]
Breakthrough T1D’s largest advocacy event – Kids For a Cure was held from November 3rd to 5th in Ottawa, Ontario. Held every two years, Kids for a Cure is Breakthrough […]
Dr. Alyssa Weinrauch is the third annual recipient of the J. Andrew McKee Fellowship in Type 1 Diabetes (T1D), jointly funded by Breakthrough T1D Canada and the Stem Cell Network […]
Since 1986, corporate Canada has been participating in one of Canada’s longest running and top fundraising events, the JDRF Ride to Defeat Diabetes. This year rides were held in Montréal […]
From September 9-13th, 2024, scientists, healthcare professionals, and the diabetes community from around the world gathered in Madrid, Spain for the European Association for the Study of Diabetes (EASD) annual […]
JDRF Canada is pleased to share that our US affiliate Breakthrough T1D (formerly JDRF, headquartered in the US) has awarded an Industry Drug and Development Grant to Integrated Nanotherapeutics (“INT”, […]
New research finds that ustekinumab, a drug commonly used to treat psoriasis, may help children and adolescents with type 1 diabetes keep making insulin for longer. Results from a clinical […]
Meet Bonnie Barber from Regina, SK, a resilient mother of seven, valued JDRF donor, and longstanding volunteer leader helping to champion JDRF Canada’s $100M Campaign to Accelerate. Bonnie shares her […]
“Alone we can do so little; together we can do so much.” – Helen Keller, Disability rights advocate Since our founding 50 years ago, JDRF Canada has helped fuel almost […]
The JDRF Canada Clinician Investigator Fellowship is open to medical residents that are pursuing an additional research degree (Master, PhD, or postdoctoral training) in the field of type 1 diabetes […]
Miguel Alvarez, who has been living with type 1 diabetes for over 55 years, aims to complete two bike rides of over 100 miles each. To mark his 55th ‘Diaversary’ […]
A large area of cure-based T1D research is investigating stem cell-based therapy. The goal of this approach is to use stem cells as a renewable source of insulin-producing cells which, […]
